Pigmentation Disorders Treatment Market Report 2025

The pigmentation disorders treatment market size has grown strongly in recent years. It will grow from $6.17 billion in 2024 to $6.69 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to topical treatment development, dermatological advancements, sunscreen and sun protection, chemical exfoliation methods, consumer awareness, and education.

The pigmentation disorders treatment market size is expected to see strong growth in the next few years. It will grow to $9.21 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to enhanced delivery systems, microbiome-based therapies, regenerative medicine adoption, rise in telemedicine services, gene therapy, and biologics. Major trends in the forecast period include skin health education programs, bio-inspired skincare solutions, non-invasive treatment modalities, neurocosmetics and psychodermatology, legal regulations, and safety standards.

The rising incidence of pigmentation disorders is anticipated to drive the growth of the pigmentation disorder treatment market in the future. Pigmentation disorders are conditions that result in abnormal or uneven coloration of the skin, hair, or eyes, caused by various factors including genetics, hormonal changes, sun exposure, or underlying medical issues. Treatment options for these disorders encompass several methods, such as topical medications, laser therapy, chemical peels, and microdermabrasion, all aimed at reducing or lightening dark spots, patches, or irregular skin pigmentation associated with conditions like albinism, melasma, vitiligo, or hyperpigmentation. For instance, in June 2024, the United Nations, a US-based intergovernmental organization, reported that in North America and Europe, about 1 in every 17,000 to 20,000 individuals is affected by some form of albinism. However, the prevalence is much higher in sub-Saharan Africa, with estimates indicating that 1 in 1,400 people in Tanzania have albinism, and some populations in Zimbabwe and specific ethnic groups in Southern Africa report rates as high as 1 in 1,000. Consequently, the increasing prevalence of pigmentation disorders is fueling the growth of the pigmentation disorders treatment market.

The substantial growth of disposable incomes worldwide is a significant contributor to the expansion of the pigmentation disorder treatment market. Rising disposable incomes, particularly in developing regions, empower individuals to allocate more resources to cosmetic and dermatological treatments. Data from October 2023 published by the Bureau of Economic Analysis revealed an increase in Americans' disposable income from $18.24 trillion in the first quarter of 2022 to $19.88 trillion in the first quarter of 2023. Consequently, the global rise in disposable incomes is expected to drive the pigmentation disorders treatment market.

A noteworthy trend in the pigmentation disorder treatment market is the integration of technological advancements. Major companies in this market are focusing on developing innovative products utilizing advanced technologies to enhance their market position. For instance, Scientis SA introduced the Cyspera Intensive System in March 2022, a comprehensive solution leveraging dual chamber technology. This system incorporates key ingredients such as Cysteamine Isobionic-Amid Complex, AHA-Amino Acid Complex, and Isobionic-Amide Complex, effectively addressing hyperpigmentation by delivering potent antioxidant activity, balancing skin pH, and providing anti-inflammatory benefits.

Companies operating in the pigmentation disorder treatment market are also placing emphasis on the development of nutricosmetics products. The integration of nutricosmetics involves using oral supplements to improve skin health and is gaining popularity. Nutrients such as antioxidants and vitamins are promoted for their potential benefits to pigmentation and overall skin condition. For instance, in March 2023, Symrise AG launched diana food bioactives, a collection of innovative nutricosmetic ingredients designed for 'Beauty from within' products. The collection includes solutions for skin conditioning, anti-aging, skin brightening, and hair and nail care, contributing to the expanding field of cosmetic ingredients.

In February 2024, Shiseido, a Japan-based cosmetics company, acquired DDG Skincare Holdings LLC for an undisclosed sum. This strategic acquisition aligns with Shiseido's goal to enhance its portfolio with scientifically validated skincare solutions. Dr. Dennis Gross Skincare is a US-based provider of treatments for pigmentation disorders.

Major companies operating in the pigmentation disorders treatment market include AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb, L’Oréal S.A., Bausch Health Companies Inc., Bayer AG, Strides Pharma Science Limited, Galderma S.A., Incyte Corporation, Dr. Reddy's Laboratories Ltd., Laboratories Pierre Fabre, Glenmark Pharmaceuticals Limited., Dermavant Sciences Inc., Lumenis Be Ltd., Accord Healthcare, Obagi Medical Products Inc., Fotona d.o.o., Sesderma SL, DermaMed Solutions LLC., Vital Esthetique, Vivier Pharma, Arcutis Biotherapeutics, Episciences Inc., Phio Pharmaceuticals Inc., Scientis SA, Philadelphia Pharmaceutical.

North America was the largest region in the pigmentation disorders treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pigmentation disorders treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pigmentation disorders treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pigmentation disorder treatment involves various methods and procedures aimed at addressing and managing conditions that affect the skin's pigmentation. These treatments are designed to restore or balance skin pigmentation, reduce the appearance of dark spots or patches, and improve overall skin tone and appearance.

The main types of pigmentation disorder treatments include topical treatment, dermabrasion, chemical peels, laser treatment, phototherapy, and others. Topical treatments involve the application of medications or products directly to the skin's surface to address various skin conditions, including pigmentation disorders. The treatment of pigmentation disorders utilizes various drugs such as calcineurin inhibitors, melanocyte-stimulating hormones, and others to address conditions such as albinism, vitiligo, melasma, post-inflammatory hyperpigmentation (PIH), and more. These drugs can be administered through oral, topical, and other routes and are distributed through dermatology clinics, aesthetic clinics, drugstores and cosmetic stores, e-commerce platforms, and other channels.

The pigmentation disorders treatment research report is one of a series of new reports that provides pigmentation disorders treatment market statistics, including the pigmentation disorders treatment industry's global market size, regional shares, competitors with a pigmentation disorders treatment market share, detailed pigmentation disorders treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pigmentation disorders treatment industry. This pigmentation disorders treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pigmentation disorders treatment market consists of revenues earned by entities by providing pigmentation disorders treatment services such as cryotherapy, light therapy, and depigmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. The pigmentation disorder treatment market also includes sales of topical creams and serums, micro needling devices, and light therapy devices that are used in pigmentation disorder treatments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.